Latest by Myles Helfand

This Week in HIV Research: Monday, Wednesday, Treatment Days

Happy days for thrice-weekly dosing; shortfalls in chronic opioid therapy monitoring; neurocognition, treatment initiation, and high CD4; the link between influenza virus shedding and CD4 count.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Where Support Is Lacking, the Virus Can Spread

Housing, social support, and HIV transmissibility among people who use drugs; concerning hepatitis C incidence trends in France; frailty among people aging with HIV; untreated HIV and brain atrophy.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: The Syphilis Surge

The rising tide of syphilis among Americans with HIV; first-line treatment with D/C/F/TAF; peculiar findings on cancer treatment rates; poor flu vaccine response among older people.

By Barbara Jungwirth and Myles Helfand

Little Promise of Anal Protection From Adult HPV Vaccination

HPV vaccination and anal (vs. oral) HPV infection; single-tablet E/C/F/TDF vs. HIV-2; an HIV-positive infant’s “founder” virus; male circumcision and antiretroviral scale-up in Kenya.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Heavier Health Burdens Begin Before Diagnosis

Prevalence of non-AIDS comorbidities prior to HIV diagnosis; wealth and HIV treatment access amidst universal health care; the uncertain benefits of food supplementation; the results of universal hepatitis C treatment access.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: The Ubiquity, and Diversity, of Substance Use

Substance use rates among people with HIV; the continuing risk of PML; tenofovir gel efficacy and menopause; the cumulative cost of the global fight against HIV.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Vitamin D for CD4? Eh.

The effect of vitamin D levels on CD4 count during HIV treatment; helping black men who have sex with men utilize PrEP; HIV and aortic stiffness; Legionnaires’ disease severity among people with HIV.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: How Discrimination Feeds Cigarette Use

Tobacco use and HIV discrimination; enhancing viral suppression after prison with naltrexone; asymptomatic myocardial impairment during acute HIV infection; undetectability and yellow fever vaccine efficacy.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Butt Wait, There's More

HIV in plasma vs. rectal mucosa; engagement in care while on PrEP; depression and outcomes among women with HIV; dolutegravir resistance in the wake of monotherapy.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Erectile Dysfunction in the Modern Age

Reductions in erectile function among men who have sex with men; Australia, San Francisco, and 90-90-90 “fast track” targets; hepatitis C infection and HIV risk; safety of the live herpes zoster vaccine.

By Barbara Jungwirth and Myles Helfand